期刊文献+

根治性切除肝细胞癌预后影响因素分析 被引量:5

ANALYSIS OF PROGNOSITIC FACTORS IN HEPATOCELLAR CARCINOMA TREATED BY RADICAL RESECTION
下载PDF
导出
摘要 目的 探讨肝细胞癌患者经根治性切除后的主要预后影响因素。方法 对 5 6例经根治性切除的患者进行回顾性统计 ,应用 Cox比例风险模型对可能影响预后的 16项指标进行了多因素分析 ,并建立生存预测方程。结果 总生存率 1,3,5年分别为89.73% ,5 4.0 8% ,2 9.12 % ,中位生存期 78.2 4月。影响肝癌预后最明显的因素是门脉癌栓、C- myc表达及肿瘤包膜。生存预测方程总χ2 =5 3.2 81,P<0 .0 0 1。按预后指数分组 ,低危组、中危组及高危组间 5年生存率具显著差异 ,P<0 .0 5。结论 肝细胞癌预后由多种因素决定 ,对于低危组及中危组患者 ,仍应积极手术治疗以期获得较好疗效。 Objective To evaluatte the major prognostic factors in patients with hepatocellar carcinoma(HCC) who were treated by radical resection.Methods 56 cases of HCC treated by radical resection were analyed retrospectoively and statisically.A multivaritate Cox model was used to analyse sixteen factors that might influence the prognosis,and the survival prediction equation.Results The overall cumulative survival rates for 1,3 and 5 years were 89.73%,54.08% and 29.12% respectively.The median duration of survival were 78.24 months.The most significant prognostic factors were tumor thrombus in the portal vein,C-mycexpression and tumor without capsule.The survival prediction equation was X 2=53.281 P<0.001.The index partitioned the patients into low risk group,intermediate group,and high risk group.Five-year survival rates in three groups were sighificant different(P<0.05).Conclution The prognosis of HCC were decided by varied factors.The Surgical treatment shoud be done actively to the patients with low risk and intermediate group in order to improve the prognosis.
出处 《肝胆外科杂志》 2000年第2期90-92,共3页 Journal of Hepatobiliary Surgery
关键词 肝细胞癌 切除 比例风险模型 预后 HCC Resection Proportional hazards models Prognosis
  • 相关文献

参考文献9

  • 1[1]Wu Mc,Chen H,Yang JM,et al.Surgical treatment of primary liver cancer.In:Tang Zy,Ye SL,ed.Recent progress in liver cancer and hepatitis.International Academic Publichers,1996,17.
  • 2王悦华,冯玉泉,刘永雄,周宁新,顾万清,黄志强,赵海潞,纪小龙.原发性肝癌的外科治疗[J].中华普通外科杂志,1997,12(6):325-328. 被引量:13
  • 3[3]Hsu HC,Shen JC,Lee CS,et al.Prognestic histologic parameters in resected small hepatocellular carcinoma:a comparison with resected large hepatocellular carcinoma.Cancer,1985,56:672.
  • 4[4]Yamamoto K,Masuzawa M,Kato M,et al.Analysis of prognostic factors on patients with hepatocellular carcinoma treated by reanscathether arterial embolization.Cancer Chemother Pharmacol,1992,31:77.
  • 5贾雨辰,刘崎,贺佳,王振堂,王飞,陈栋,孙飞,田建明,叶华,陆建平.Cox模型对肝癌预后因素的分析[J].中华放射学杂志,1996,30(2):80-84. 被引量:29
  • 6李华.多基因变异与肝细胞癌[J].实用肿瘤学杂志,1998,12(1):76-80. 被引量:3
  • 7[7]Yaswen P,Goyetta M,Shank P,et al.Expression of C-ki-ras,C-ha-ras and C-myc in specific cell types during hepatocarcinogenesis.Mol Cell Biol,1985,5:780.
  • 8陈子华,吕新生,文继舫,沈明.原癌基因Jun/C-myc在原发性肝细胞癌中的表达及意义[J].中华实验外科杂志,1997,14(5):277-278. 被引量:8
  • 9[9]Takenaka K,Kawahara N,Yamamoto K,et al.Result of 280 liver resections for hepatocellular carsinoma.Arch Surg,1996,131:71.

二级参考文献17

共引文献45

同被引文献50

引证文献5

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部